|1.||Sato, Mayumi: 2 articles (03/2015 - 02/2012)|
|2.||Sakai, Fumihiko: 2 articles (03/2015 - 02/2012)|
|3.||Iizuka, Takahiro: 2 articles (03/2015 - 02/2012)|
|4.||Hamada, Junichi: 2 articles (03/2015 - 02/2012)|
|5.||Akutsu, Tsugio: 1 article (03/2015)|
|6.||Tominaga, Naomi: 1 article (03/2015)|
|7.||Nishiyama, Kazutoshi: 1 article (03/2015)|
|8.||Kaneko, Juntaro: 1 article (03/2015)|
|9.||Hayes, Julie: 1 article (09/2012)|
|10.||Doherty, Ann T: 1 article (09/2012)|
02/01/2012 - "The authors performed serial neuroimaging studies during acute stage and after recovery of aura symptoms in eight HMPA attacks in two affected individuals of the Japanese family of FHM during a 10-year-observational period. "
03/01/2015 - "We evaluated CBF at different phases of aura symptoms in 11 attacks of HMPA. "
03/01/2015 - "We assessed neurovascular changes with time in the affected cerebral hemisphere corresponding to aura symptoms during the acute phase of HMPA. "
03/01/2015 - "To report biphasic changes in cerebral blood flow (CBF) in the acute phase of hemiplegic migraine with prolonged aura (HMPA), in which aura symptoms lasted longer than 24 h, in three patients with familial hemiplegic migraine (FHM) carrying a p.H916L mutation in ATP1A2 gene. "
|2.||Chromosome Aberrations (Chromosome Abnormalities)
09/01/2012 - "Chromosome aberration frequency in rat peripheral lymphocytes increases with repeated dosing with hexamethylphosphoramide or cyclophosphamide."
09/01/2012 - "Therefore, in the current study, after optimising culture conditions for rat lymphocytes in this laboratory, rats were given oral doses of cyclophosphamide or hexamethylphosphoramide (HMPA) for up to 28 days and peripheral lymphocytes analysed for chromosome aberrations at various time points. "
01/01/2012 - "The aim of this study therefore was to analyze the impact of synchronous liver-directed therapy on operative outcome and overall survival in patients with hepatic metastasized pancreatic adenocarcinoma (HMPA). "
01/01/2012 - "22 patients who underwent simultaneous pancreas resection and liver-directed therapy for HMPA between January 1, 2004 and January 1, 2009 were compared to 22 patients who underwent classic pancreas resection for nonmetastasized pancreatic adenocarcinoma (NMPA) in a matched pair study design. "
02/01/1984 - "Morphogenesis of nasal tumors in rats exposed to hexamethylphosphoramide by inhalation."
01/01/1982 - "Induction of nasal tumors in rats exposed to hexamethylphosphoramide by inhalation."
07/01/1995 - "However, induction of tumor formation after two years at 50 ppb HMPA and 6 ppm formaldehyde show the former to be active at several-fold lower concentrations. "
02/01/1984 - "Nasal tumors were induced in rats by inhalation exposure to hexamethylphosphoramide (HMPA) for 6 to 24 months at concentrations of 50, 100, 400, and 4000 parts per billion (ppb), but not in rats exposed at 10 ppb for 24 months. "
01/01/1982 - "Rats exposed by inhalation to hexamethylphosphoramide (HMPA) at concentrations of 50, 100, 400, and 4000 parts per billion (ppb) for 6-24 months revealed nasal tumors and squamous metaplasia with inflammation in the nasal epithelium, but no changes were observed at 10 ppb. "
01/01/1969 - "Hempa at a toxic dose induced complete sterility. "
04/01/1970 - "Mating ability and permanency of sterility in hempa-sterilized males of the yellow-fever mosquito, Aedes aegypti (L.)."
12/01/1969 - "Induced sterility in face fly--initial and sustained effects of hempa and metepa."
01/01/1969 - "For larval treatment, hempa was better than hemel in inducing sterility while for pupal treatment the latter was better than hempa. "
|3.||N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)
|4.||Dihydrotachysterol (AT 10)
|5.||A-Form DNA (A-DNA)
|8.||Adenosine Triphosphate (ATP)
|9.||Adenosine Diphosphate (ADP)